Molecular Basis of Hyper lgE Immunodeficiency
高 lgE 免疫缺陷的分子基础
基本信息
- 批准号:7758764
- 负责人:
- 金额:$ 34.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-01 至 2011-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAllergicAllergic inflammationAntibody FormationAntigensApoptoticAsthmaAttenuatedB-LymphocytesBindingCell Culture TechniquesChronicEnhancing AntibodiesEpithelial CellsEventEvolutionGene TargetingGenesGenetic PolymorphismGoblet CellsITIMImmunologic Deficiency SyndromesInflammatory ResponseInterleukin 4 ReceptorInterleukin-13Interleukin-4InterventionKnock-in MouseLigandsMediatingMedicalMemoryMetaplasiaMicroarray AnalysisMolecularMusMutagenesisMutant Strains MiceMutationPhenylalaninePlayReceptor SignalingRegulationRoleSignal PathwaySignal TransductionSpecificityStreamTestingTissuesTransgenic AnimalsTyrosineairway hyperresponsivenessallergic airway inflammationbasein vivomutantnovelresponsetranscription factor
项目摘要
The interleukin 4 receptor alpha chain (IL-4Ra) plays a key role in allergic inflammatory
responses. However, whereas the function of its dedicated transcription factor Stat6 in
promoting allergic inflammation is well established, those of the other two signaling
branches down-stream of the IL-4Ra I4R and ITIM motifs remains unclear. By
employing a targeted gene knock-in approach that inactivated the I4R motif by
mutagenesis of its effector tyrosine residue into phenylalanine (Y500F), we have
demonstrated novel tissue and ligand-specific functions of this motif. The Y500F
mutation enhanced antigen-driven antibody responses and allergic airway inflammation,
consistent with a negative regulatory function of the I4R motif in receptor signaling.
Remarkably however, I4R mutagenesis selectively impaired two cardinal effects of DL-13
on resident airway tissues, including induction of airway hyper-responsiveness (AHR)
and metaplasia of primary tracheal epithelial cell cultures into goblet cells, while sparing
the induction of the same events by IL-4. To examine the mechanism of enhanced
antibody response in Y500F mutants, we propose to test the hypothesis that the I4R motif
down-regulates DL-4Ra signaling in B cells and identify the molecular basis of this
function. To probe the function of the I4R motif in IL-13 signaling in resident airway
tissues, we propose to examine the hypothesis that signaling via the I4R motif mediates
key EL-13 responses in airway epithelial cells relevant to AHR and goblet cell metaplasia,
and that it mediates aspects of IL-13-dependent chronic structural airway changes.
Finally, we propose to employ newly derived mice in which the ITIM motif has been
inactivated by mutagenesis of its effector tyrosine residue (Y709F) to address the in vivo
function of this motif in IL-4Ra signaling and allergic inflammation. These studies will
identify fundamental regulatory mechanisms involved in allergic inflammation and help
devise targeted interventions in related medical conditions including asthma.
白介素4受体α链(IL-4RA)在过敏性炎症中起关键作用
回答。但是,尽管其专用转录因子STAT6的功能
促进过敏性炎症已经很好地确定,其他两个信号传导的炎症
IL-4RA I4R和ITIM图案的分支下游仍不清楚。经过
采用针对性的基因敲入方法,通过
其效应子酪氨酸残基到苯丙氨酸(Y500F)的诱变,我们有
展示了该基序的新组织和配体特异性功能。 Y500F
突变增强了抗原驱动的抗体反应和过敏性气道炎症,
与I4R基序在受体信号传导中的负调控功能一致。
但是,I4R诱变有选择地损害了DL-13的两个基本效应
在常驻气道组织上,包括诱导气道高反应性(AHR)
一级气管上皮细胞培养在杯状细胞中的转移,同时保留
IL-4诱导相同事件。检查增强的机制
Y500F突变体中的抗体反应,我们建议测试I4R基序的假设
下调B细胞中的DL-4RA信号传导,并确定其分子基础
功能。探测居民气道IL-13信号中I4R基序的功能
组织,我们建议检查以下假设
气道上皮细胞中的关键EL-13响应与AHR和Goblet细胞化生有关,
并且它介导了IL-13依赖性慢性结构气道的变化。
最后,我们建议采用新衍生的小鼠,其中ITIM图案已成为
由于其效应酪氨酸残基(Y709F)的诱变而灭活以解决体内
该基序在IL-4RA信号传导和过敏性炎症中的功能。这些研究会
确定涉及过敏性炎症和帮助的基本调节机制
在包括哮喘在内的相关医疗状况中设计有针对性的干预措施。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CaMKIV/Gr is dispensable for spermatogenesis and CREM-regulated transcription in male germ cells.
- DOI:10.1152/ajpendo.2001.281.5.e931
- 发表时间:2001-11
- 期刊:
- 影响因子:0
- 作者:F. Blaeser;J. Toppari;M. Heikinheimo;W. Yan;M. Wallace;N. Ho;T. Chatila
- 通讯作者:F. Blaeser;J. Toppari;M. Heikinheimo;W. Yan;M. Wallace;N. Ho;T. Chatila
Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation.
CD40 配体亚态突变揭示了细小病毒 B19 感染中 CD40 通路的关键功能。
- DOI:10.1016/j.clim.2005.08.005
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Blaeser,Frank;Kelly,Michael;Siegrist,Karen;Storch,GregoryA;Buller,RichardS;Whitlock,Jessica;Truong,Nga;Chatila,TalalA
- 通讯作者:Chatila,TalalA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Talal Amine Chatila其他文献
Talal Amine Chatila的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Talal Amine Chatila', 18)}}的其他基金
Targeting microbial dysbiosis in Food Allergy to restore tolerance
针对食物过敏中的微生物失调以恢复耐受性
- 批准号:
10549764 - 财政年份:2021
- 资助金额:
$ 34.57万 - 项目类别:
Targeting microbial dysbiosis in Food Allergy to restore tolerance
针对食物过敏中的微生物失调以恢复耐受性
- 批准号:
10185766 - 财政年份:2021
- 资助金额:
$ 34.57万 - 项目类别:
Novel NOTCH4 Pathway of Asthma Severity in Urban School Children: Clinical Research Center, Boston Children’s Hospital
城市学童哮喘严重程度的新型 NOTCH4 途径:波士顿儿童医院临床研究中心
- 批准号:
10210940 - 财政年份:2021
- 资助金额:
$ 34.57万 - 项目类别:
Novel NOTCH4 Pathway of Asthma Severity in Urban School Children: Clinical Research Center, Boston Children’s Hospital
城市学童哮喘严重程度的新型 NOTCH4 途径:波士顿儿童医院临床研究中心
- 批准号:
10592358 - 财政年份:2021
- 资助金额:
$ 34.57万 - 项目类别:
Targeting microbial dysbiosis in Food Allergy to restore tolerance
针对食物过敏中的微生物失调以恢复耐受性
- 批准号:
10359843 - 财政年份:2021
- 资助金额:
$ 34.57万 - 项目类别:
Novel NOTCH4 Pathway of Asthma Severity in Urban School Children: Clinical Research Center, Boston Children’s Hospital
城市学童哮喘严重程度的新型 NOTCH4 途径:波士顿儿童医院临床研究中心
- 批准号:
10392449 - 财政年份:2021
- 资助金额:
$ 34.57万 - 项目类别:
Genetic and Epigenetic Programming of Allergic Airway Inflammation
过敏性气道炎症的遗传和表观遗传编程
- 批准号:
10169796 - 财政年份:2020
- 资助金额:
$ 34.57万 - 项目类别:
Effect of IL-4RαR576 variant on response to Dupilumab in children with Asthma
IL-4RαR576 变异对哮喘儿童 Dupilumab 反应的影响
- 批准号:
10592379 - 财政年份:2019
- 资助金额:
$ 34.57万 - 项目类别:
Effect of IL-4RαR576 variant on response to Dupilumab in children with Asthma
IL-4RαR576 变异对哮喘儿童 Dupilumab 反应的影响
- 批准号:
10386768 - 财政年份:2019
- 资助金额:
$ 34.57万 - 项目类别:
Effect of IL-4RαR576 variant on response to Dupilumab in children with Asthma
IL-4RαR576 变异对哮喘儿童 Dupilumab 反应的影响
- 批准号:
9912720 - 财政年份:2019
- 资助金额:
$ 34.57万 - 项目类别:
相似国自然基金
CD207阳性树突状细胞在过敏性哮喘气道炎症中作用及机制研究
- 批准号:82370035
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IL-38调控嗜酸性粒细胞胞外诱捕网形成缓解过敏性哮喘气道炎症的机制研究
- 批准号:82302011
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
难治性过敏性鼻炎中更昔洛韦相关的特殊炎症机制及作用靶点探究
- 批准号:82371124
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CX3CR1+CD4+CTL细胞通过Nrf-2/NKG7介导上皮细胞毒性在过敏性哮喘气道炎症中的作用机制研究
- 批准号:82270034
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
CD5L上调脂肪酸合成酶抑制ILC2减轻过敏性哮喘气道炎症的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Heterogeneity and cellular hierarchy of lung cDC2
肺 cDC2 的异质性和细胞层次
- 批准号:
10665348 - 财政年份:2023
- 资助金额:
$ 34.57万 - 项目类别:
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
- 批准号:
10677304 - 财政年份:2023
- 资助金额:
$ 34.57万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 34.57万 - 项目类别:
Neuronally-driven accumulation of glycolytic MafB+MHCIIhi IMs drive airway allergy
神经元驱动的糖酵解 MafB MHCIIhi IM 积累导致气道过敏
- 批准号:
10736048 - 财政年份:2023
- 资助金额:
$ 34.57万 - 项目类别:
Mammary Epithelium Permeability, Lactation Outcomes, and Infant Health
乳腺上皮渗透性、哺乳结果和婴儿健康
- 批准号:
10753649 - 财政年份:2023
- 资助金额:
$ 34.57万 - 项目类别: